Aileron Therapeutics (ALRN) Q1 2023 Earnings

3MayExpected
May 22
Aug 22
Nov 22
Q1 2023
-1.8
-1.49
-1.17
-0.86

Details

Expected EPS
-0.86
Actual EPS
-1.02
Surprise EPS
-0.16
Surprise Percent
+18.6%

Description

Aileron Therapeutics (ALRN) has reported earnings of -1.02 per share for Q1 2023.

0 Comments

Share your thoughts